These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18411765)

  • 41. Endogenous Scedosporium apiospermum endophthalmitis.
    Jain A; Egbert P; McCulley TJ; Blumenkranz MS; Moshfeghi DM
    Arch Ophthalmol; 2007 Sep; 125(9):1286-9. PubMed ID: 17846376
    [No Abstract]   [Full Text] [Related]  

  • 42. Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
    Whyte M; Irving H; O'Regan P; Nissen M; Siebert D; Labrom R
    Pediatr Infect Dis J; 2005 Apr; 24(4):375-7. PubMed ID: 15818301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of voriconazole in Scedosporium apiospermum keratitis.
    Lai TF; Malhotra R; Esmail-Zaden R; Galanopoulas A; Chehade M; Selva D
    Cornea; 2003 May; 22(4):391; discussion 391-2. PubMed ID: 12792490
    [No Abstract]   [Full Text] [Related]  

  • 44. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Imataki O; Yamaguchi K; Uemura M; Fukuoka N
    Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
    Ananda-Rajah MR; Grigg A; Slavin MA
    Mycopathologia; 2008 Aug; 166(2):83-6. PubMed ID: 18512130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
    Tong SY; Peleg AY; Yoong J; Handke R; Szer J; Slavin M
    Transpl Infect Dis; 2007 Sep; 9(3):241-3. PubMed ID: 17605752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous hyalohyphomycosis by Scedosporium apiospermum in an immunocompromised patient.
    Makino K; Fukushima S; Maruo K; Egawa K; Nishimoto K; Ihn H
    Mycoses; 2011 May; 54(3):259-61. PubMed ID: 19889175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    Fukushima K; Fujisawa M; Nakajima D; Matsunaga T; Hagisawa S; Kurosawa H; Sugita K; Arisaka O
    Rinsho Ketsueki; 2007 May; 48(5):402-6. PubMed ID: 17571586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature.
    Farina C; Gotti E; Suter F; Goglio A
    Transplant Proc; 2006 Jun; 38(5):1333-5. PubMed ID: 16797295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cutaneous and osteoarticular Scedosporium apiospermum infection].
    Fays S; Di Cesare MP; Antunes A; Truchetet F
    Ann Med Interne (Paris); 2002 Dec; 153(8):537-9. PubMed ID: 12610428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report.
    Chakraborty A; Workman MR; Bullock PR
    J Neurosurg; 2005 Jul; 103(1 Suppl):83-7. PubMed ID: 16122011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient.
    Chaveiro MA; Vieira R; Cardoso J; Afonso A
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):47-9. PubMed ID: 12602968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
    Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
    Symoens F; Knoop C; Schrooyen M; Denis O; Estenne M; Nolard N; Jacobs F
    J Heart Lung Transplant; 2006 May; 25(5):603-7. PubMed ID: 16678041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
    Holle J; Leichsenring M; Meissner PE
    J Cyst Fibros; 2014 Jul; 13(4):400-2. PubMed ID: 24263169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Case of Cutaneous Mycosis Caused by Scedosporium dehoogii on an Immunocompromised Patient.
    Sakata Y; Taga F; Ushigami T; Takeda K; Anzawa K; Nishibu A; Mochizuki T
    Mycopathologia; 2018 Apr; 183(2):465-470. PubMed ID: 28864936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
    Racil Z; Winterova J; Kouba M; Zak P; Malaskova L; Buresova L; Toskova M; Lengerova M; Kocmanova I; Weinbergerova B; Timilsina S; Rolencova M; Cetkovsky P; Mayer J
    Mycoses; 2012 Nov; 55(6):483-92. PubMed ID: 22429709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous infection by Fusarium: successful treatment with oral voriconazole.
    Guimerá-Martín-Neda F; García-Bustínduy M; Noda-Cabrera A; Sánchez-González R; Montelongo RG
    Br J Dermatol; 2004 Apr; 150(4):777-8. PubMed ID: 15099384
    [No Abstract]   [Full Text] [Related]  

  • 59. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
    Huang CY; Sun PL; Tseng HK
    Mycopathologia; 2011 Aug; 172(2):141-5. PubMed ID: 21424606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient.
    Bower CP; Oxley JD; Campbell CK; Archer CB
    J Clin Pathol; 1999 Nov; 52(11):846-8. PubMed ID: 10690177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.